Terminated PHASE1 INTERVENTIONAL NCT00427102

MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck

A Phase 1 Study of Oral MRX-1024 in Combination With Standard Fractionation Radiation Therapy and High-Dose Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck Following Surgical Resection

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions Head and Neck Cancer Mucositis Resected Head and Neck Cancer Squamous Cell Carcinoma

Interventions High-Dose Cisplatin Chemotherapy Oral MRX-1024 Standard Fractionation Radiation Therapy

Updated 5 times since 2017 Last updated: Nov 13, 2012 Started: Jan 31, 2007 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No subjects enrolled and PI went to another facility

Other terminated trials from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

See all terminations from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Other Head and Neck Cancer trials with similar outcome

Browse all Head and Neck Cancer trials

A PHASE1 clinical study on Head and Neck Cancer and Mucositis, this trial is terminated or withdrawn. The trial is conducted by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and has accumulated 5 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Data source: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.